Physician profile
Daniel E Swanson
NPI 1447575154
$2,238.09
in general payments reported to CMS, 2019-2025
19 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $850 · 2020: $126 · 2021: $177 · 2022: $254 · 2023: $303 · 2024: $290 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $747.53 | 2019 | |
| Axonics, INC. | $286.58 | 2023 | Axonics |
| Olympus America INC. | $169.88 | 2020-2025 | Olympus |
| Urogen Pharma, INC. | $150.20 | 2022 | |
| Sumitomo Pharma America, INC. | $143.04 | 2024 | Gemtesa |
| Coloplast Corp | $139.48 | 2024-2025 | |
| Astellas Pharma Global Development | $118.44 | 2021-2022 | |
| Allergan, INC. | $107.14 | 2021 | |
| Boston Scientific Corporation | $105.90 | 2024-2025 | Lithovue, Lumenis Pulse 120h |
| Covidien LP | $68.75 | 2019 | |
| Abbvie INC. | $39.49 | 2025 | |
| Myriad Genetic Laboratories, INC. | $38.00 | 2022-2023 | Prolaris |
| 180 Medical, INC. | $26.16 | 2025 | |
| Emd Serono, INC. | $25.24 | 2022 | |
| Amgen INC. | $17.47 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $16.53 | 2024 | Endosheath Technology |
| Novartis Pharmaceuticals Corporation | $16.34 | 2019 | |
| Innovation Technologies INC | $14.28 | 2025 | Irrisept |
| Travere Therapeutics, INC. | $7.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.